Assessing the impact of COVID-19 on liver cancer management (CERO-19) / Sergio Muñoz-Martínez, 1; Victor Sapena, 1; Alejandro Forner, 1; 2 3 4, Jean-Charles Nault; Gonzalo Sapisochin, 5; 6 7, Lorenza Rimassa; Bruno Sangro, 8; Jordi Bruix, 1; Marco Sanduzzi-Zamparelli, 1; Wacław Hołówko, 9; Mohamed El Kassas 10, ; Tudor Mocan 11, ; Mohamed Bouattour 12, ; Philippe Merle 13, ; Frederik J, H Hoogwater 14; Saleh, A Alqahtani 15; Helen, L Reeves 16; David, J Pinato 17; Emmanouil Giorgakis 18, ; Tim Meyer 19, ; Gerda Elisabeth Villadsen 20, ; Henning Wege 21, ; Massimiliano Salati 22, ; Beatriz Mínguez 23, ; Giovan Giuseppe Di Costanzo 24, ; Christoph Roderburg 25, ; Frank Tacke 25, ; María Varela 26, ; Peter, R Galle 27; Mario Reis Alvares-da-Silva 28, ; Jörg Trojan 29, ; John Bridgewater 30, ; Giuseppe Cabibbo 31, ; Christian Toso 32, ; Anja Lachenmayer 33, ; Casadei-Gardini, Andrea; Hidenori Toyoda 35, ; Tom Lüdde 36, ; Rosanna Villani 37, ; Ana María Matilla Peña 38, ; Cassia Regina Guedes Leal 39, ; Monica Ronzoni 40, ; Manuel Delgado 41, ; Christie Perelló 42, ; Sonia Pascual 43, ; José Luis Lledó 44, ; Josepmaria Argemi 45, ; Bristi Basu 46 47, ; Leonardo Da Fonseca 48, ; Juan Acevedo 49, ; Alexander, R Siebenhüner 50; Chiara Braconi 51, ; Brandon, M Meyers 52; Alessandro Granito 53, ; Margarita Sala 54, ; Carlos Rodríguez-Lope 55, ; 2 3 4, Lorraine Blaise; Manuel Romero-Gómez 56, ; Federico Piñero 57, ; Dhanny Gomez 58, ; Vivianne Mello 59, ; Rogerio Camargo Pinheiro Alves 60, ; Alex França 61, ; Fernanda Branco 62, ; Giovanni Brandi 63, ; Gustavo Pereira 64, ; Susanna Coll 65, ; Maria Guarino 66, ; Carlos Benítez 67, ; Maria Margarita Anders 68, ; Juan, C Bandi 69; Mercedes Vergara 70 71 72, ; Mariona Calvo 73, ; Markus Peck-Radosavljevic 74, ; Ignacio García-Juárez 75, ; Vincenzo Cardinale 76, ; Mar Lozano 77, ; Martina Gambato 78 79, ; Stefano Okolicsanyi 80, ; Dalia Morales-Arraez 81, ; Alessandra Elvevi 82, ; Alberto, E Muñoz 83; Alberto Lué 84, ; Massimo Iavarone 85, ; Maria Reig, 1. - In: JHEP REPORTS. - ISSN 2589-5559. - 3:3(2021), p. 100260. [10.1016/j.jhepr.2021.100260]

Assessing the impact of COVID-19 on liver cancer management (CERO-19)

Andrea Casadei-Gardini;
2021-01-01

File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/183977
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 49
  • ???jsp.display-item.citation.isi??? 42
social impact